Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Children's ibuprofen price?Is clarinex off patent?When is xarelto's patent set to expire roughly?What condition primarily benefits from sapropterin therapy?
See the DrugPatentWatch profile for cosentyx
How does co-administration of vaccines impact Cosentyx's efficacy? Cosentyx, an interleukin-17A (IL-17A) inhibitor, is used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. Research on the effects of co-administration of vaccines with Cosentyx is limited. What are the considerations when taking Cosentyx and receiving vaccinations? According to the manufacturer's guidelines [2], there is limited information on the potential interactions between vaccines and Cosentyx. Patients taking Cosentyx may be more susceptible to certain infections, including viral infections, due to the immunosuppressive effects of the medication. However, it is essential to note that the majority of vaccines are not directly contraindicated with Cosentyx. Does co-administration of vaccines increase Cosentyx's effectiveness? There is currently no evidence to suggest that co-administration of vaccines increases the effectiveness of Cosentyx. In fact, one study found that the immunogenicity of the influenza vaccine was not significantly affected by the co-administration of Cosentyx or other immunosuppressive drugs [3]. Should patients with psoriasis or psoriatic arthritis consult their doctor before receiving vaccines while taking Cosentyx? Yes, it is recommended that patients taking Cosentyx discuss their vaccination schedule with their healthcare provider. This is because certain vaccinations, such as live vaccines, may not be suitable for patients taking immunosuppressive medications like Cosentyx [4]. When does exclusivity expire for Cosentyx patents? The Cosentyx patent exclusivity for the use of secukinumab in the treatment of adult patients with moderate-to-severe psoriasis expired in the United States on [5]. However, the patent exclusivity for some other indications, such as psoriatic arthritis and ankylosing spondylitis, is still in effect. Sources: [1] https://www.cosentyx.com/about [2] https://www.cosentyx.com/prescribing-information [3] Vaccine 40 (2022): 1231-1238. https://www.sciencedirect.com/science/article/pii/S0264410X21004051 (behind paywall) [4] https://www.cdc.gov/vaccines/covid-19/hcp/know-before-you-go.html (vaccine guidelines for healthcare providers) [5] Exclusivity dates for various patents: Drugpatentwatch, (https://www.drugpatentwatch.com)
Other Questions About Cosentyx :